Vaccine: HEPA, MMRV, MMRV, MMRV, MMRV, RV5, VARCEL, VARCEL, VARCEL, VARCEL, VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Precautionary AE for vaccines that experienced a temperature excursion on 04/28/2025 and may have been administered. HBP (who is also a medical assistant) reported that she does not believe that they were administered, but is not certain.; This invalid spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender (number of patient or patients was not specified).   The patient's medical history, concurrent conditions and concomitant therapies were not reported.   A precautionary adverse event (AE) for vaccines that experienced a temperature excursion on 28-APR-2025 and may have been administered (for VARIVAX and PROQUAD: -3.77C (time frame: 1 hour 45 minutes 0 seconds); for ROTATEQ and VAQTA: 14.6C (time frame: 12 hours 0 minutes 0 seconds)).   On an unknown  date in April 2025 (28-APR-2025 or 29-APR-2025), the patient was vaccinated with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot #Y017062, expiration date: 11-Oct-2026) (The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT)); with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot #X023717, expiration date: 26-Sep-2025) (The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT)); with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot #Y019318, expiration date: 21-Nov-2026) (The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT)); with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot #Y015559, expiration date: 16-Sep-2026) (The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT)); with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot #Y011018, expiration date: 18-Jun-2026) (The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT)); with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Y013571, expiration date: 03-Feb-2026) (The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT)); with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Z005150, expiration date: 25-Aug-2026) (The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT)); with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Y017204, expiration date: 13-Apr-2026) (The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT)); with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Y018154, expiration date: 29-Apr-2026) (The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT)); with a dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) (lot # and expiration date were not reported); with a dose of Hepatitis A Vaccine, Inactivated (VAQTA) (lot # and expiration date were not reported) (dosages, routes of administration and vaccination sites were not provided) all administered for prophylaxis. The medical assistant reported that she did not believe that they were administered, but was not certain (product storage error). If any were administered, the date of administration was either 28-APR-2025 or 29-APR-2025. No additional information was noted. No additional AE and no product quality complaint (PQC) was noted (no adverse event). No previous temperature excursion was reported.  Lot # is being requested and will be submitted if received  This case was considered to be invalid due to lack of patient's identifiers.